OMNI®
SURGICAL SYSTEM

Target three points of resistance
with one intelligent device
Eye picture

ONLY OMNI CAN

The OMNI® Surgical System from Sight Sciences is the first and only glaucoma device indicated for canaloplasty followed by trabeculotomy for patients with primary open-angle glaucoma that allows you to:
PERFORM
Two implant-free procedures in both standalone MIGS and combo cataract
TARGET
Three points of resistance intended to lower IOP*
DELIVER
Sustained long-term IOP reduction1
RELY
On an established reimbursement code
*Trabecular meshwork (trabeculotomy), Schlemm’s canal (canaloplasty), and collector channels (canaloplasty).
1 Klabe K, et al. 2021 Jul 20. Clin Ophthalmol. 15:3121-3129.
Advancement has never
felt so good
Experience the Ergo-Series of the OMNI® Surgical System

KEY FEATURES OF THE ERGO-SERIES

News and Events
October 1-3
Join Sight Sciences at AAO 2022 in Chicago on October 1-3

Learn more by visiting: http://www.sightsciences.com/aao

March 9, 2023
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
GET TO KNOW THE ERGO-SERIES TODAY

    State